How We’re Searching for the Best Ways to Help in 2026

Key Takeaways

• GiveWell aims to grant $500M to high‑impact programs in 2026
• Research team expanded to 60 staff across 11 subteams
• Malaria subteam focuses on SMC, net gaps, and new vector tools
• Nutrition team explores vitamin A, anemia, and acute malnutrition cost cuts
• Water team pivots to alternative treatment tech and large‑scale partnerships

Pulse Analysis

GiveWell’s 2026 roadmap reflects a maturing effective‑altruism infrastructure that can translate rigorous research into sizable grantmaking. By committing $500 million to interventions with proven cost‑effectiveness, the organization not only scales impact but also signals to the broader philanthropic ecosystem that data‑driven decision‑making can handle large capital flows. The expansion to 60 researchers across eleven specialized subteams underscores a strategic shift from narrow program focus to a diversified portfolio that includes disease control, nutrition, water safety, and economic empowerment.

The malaria subteam, the largest with fifteen experts, will deepen work on seasonal malaria chemoprevention, seek gaps in insecticide‑treated net coverage, and pilot novel vector‑control tools such as spatial repellents. Nutrition researchers are probing vitamin‑A supplementation, iron‑fortified foods, and cost‑reduction pathways for acute malnutrition treatment, while the vaccination team scales caregiver‑incentive models and evaluates malaria‑vaccine prospects. In water, GiveWell moves beyond chlorination to explore ultraviolet purification, filtration kiosks, and partnerships with multilateral development banks that could embed treatment technologies in large‑scale infrastructure projects. Livelihoods work tests cash‑transfer dynamics and ultra‑poor graduation schemes, aiming to generate evidence that could justify broader philanthropic investment.

For donors, the plan offers a clear, evidence‑backed avenue to maximize lives saved per dollar. The emphasis on rapid pilots, external validation and transparent reporting helps mitigate the uncertainty inherent in scaling novel interventions. As GiveWell refines cost‑effectiveness estimates and publishes uncertainty analyses, it not only improves its own grantmaking but also contributes methodological advances that other charities can adopt. The 2026 agenda therefore serves as both a funding engine and a learning laboratory, positioning GiveWell at the forefront of impact‑oriented philanthropy.